Debu Tripathy, M.D.

The most powerful tool we have against colorectal cancer is awareness: an understanding of what the disease is, of the need to prevent it and diagnose it early, and of how best to accomplish those goals.

While science sometimes moves forward in quantum leaps, it more often advances in small steps, and this year's San Antonio Breast Cancer Symposium demonstrated both sides of that coin.

Most non-Hodgkin lymphomas can be cured, but new drugs are needed.

What should we do with low-risk cancers?

Editor-in-chief Debu Tripathy comments on the Summer issue of CURE.

CURE editor-in-chief Debu Tripathy introduces readers to the CURE Spring 2014 issue.

CURE's editor addresses the high cost of cancer care.

Pancreatic cancer as a paradigm.

Researchers gathered for the 10th annual meeting of the Society for Integrative Oncology.

The U.S. Supreme Court decides against patents on human genes.

What does personalized medicine actually mean?

Think about the long-term consequences of cancer treatment.

The number of cancers and scenarios to respond to chemoradiation therapy has grown.

Adherence to oral anticancer medication—a report card.

There are now more options for treating advanced colorectal cancer.

Becoming an effective partner in managing metastatic cancer.

Hormone therapy for breast cancer: built on success.

Editor Debu Tripathy, MD, explains the shifts in causation, biology and treatment of head and neck cancer.

Editor Debu Tripathy, MD, highlights the need for new treatments needed for bladder cancer and other stories in CURE.

New research, discoveries in Hodgkin lymphoma

The term “stem cells” has taken on a scientific, political and conversational context over the past few years for many reasons.

We are retooling clinical trials, but are not sure that this will all work quite yet.

New directions in surgery, treatment and reconstruction are changing breast cancer.

The right journalism for the right audience.

Personalizing the intangibles: mindfulness as a common path

Clinical trial enrollment, and why it matters to all of us.

Spring 2010 Letter from the Editor

Why issues that impact minorites with cancer affect everyone.

The relationship between a tumor and the surrounding environment is complex, with each influencing the other.